retatrutide clinical data Reta trial & dosing — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 trials for metabolic health — targeting GLP-1, GIP New Phase 3 retatrutide data

However, in a Canadian proof-of-principle, double-blind, randomised, placebo-controlled study (NCT02141035) in 20 patients with severe carpal tunnel syndrome, acetyl-l-carnitine did not improve nerve regeneration or functional recovery following surgery

It should be avoided in the following cases: We understand that you may have questions about semaglutide

DOI: 10.1056/NEJMoa2502081 Davies MJ, Bajaj HS, Broholm C, Christiansen E, Fink LN, Hussein Z, et al

In order to gain a comprehensive overview of the situation, discuss and identify possible additional solutions, the MSSG is organising a multistakeholder workshop on 1 July 2024

What is a Medication Deferral